{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P16410",
      "entity_text" : "CTLA-4",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0571" ],
      "Organ" : [ "uberon:UBERON:0002405" ],
      "CellType" : [ "cl:CL:0000084" ]
    }
  },
  "verbose_text" : "Improved anti-tumor activity and a more favorable phenotype of CD8+ T cells with increased CTLA-4 expression in the pulsatile group inspired us to test the combination of pulsatile MEKi treatment with an anti-CTLA4 antibody in Kras mutant lung cancer.",
  "reading_complete" : "2020-08-08T10:51:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T10:49:20Z",
  "trigger" : "expression",
  "evidence" : [ "CTLA-4 expression" ],
  "pmc_id" : "6719696",
  "score" : 0
}